After ACS without PCI, how long should a P2Y12 inhibitor be continued?

Study for the Anticoagulation and ACS Exam with tailored flashcards and multiple choice questions, each featuring hints and detailed explanations. Prepare effectively and ensure success on your exam with confidence!

Multiple Choice

After ACS without PCI, how long should a P2Y12 inhibitor be continued?

Explanation:
After ACS managed without PCI, continuing a P2Y12 inhibitor alongside aspirin for about six to twelve months is recommended. This duration strikes a balance between preventing recurrent ischemic events and limiting bleeding risk. Shortening to only a few weeks or months leaves patients at higher risk for recurrence, while extending beyond a year increases bleeding without clear added benefit for those not treated with PCI. Therefore, six to twelve months is the standard target window.

After ACS managed without PCI, continuing a P2Y12 inhibitor alongside aspirin for about six to twelve months is recommended. This duration strikes a balance between preventing recurrent ischemic events and limiting bleeding risk. Shortening to only a few weeks or months leaves patients at higher risk for recurrence, while extending beyond a year increases bleeding without clear added benefit for those not treated with PCI. Therefore, six to twelve months is the standard target window.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy